<DOC>
	<DOC>NCT00857753</DOC>
	<brief_summary>Tohe purpose of this study is to demonstrate the bioequivalence of a fentanyl patch transdermal delivery system.</brief_summary>
	<brief_title>Relative Bioavailability of a Fentanyl Patch</brief_title>
	<detailed_description />
	<mesh_term>Fentanyl</mesh_term>
	<criteria>No clinically significant abnormal findings on physical exam, medical history or clinical laboratory tests on screening. Negative test for HIV and hepatitis B and C No history of drug or alcohol treatment No allergies to opiates</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>